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Abstract
Background: To investigate the average and extrapolated excess length of stay and direct costs of adverse events
(AEs) and preventable AEs in Dutch hospitals, and to evaluate patient characteristics associated with excess length
of stay and costs.
Methods: Data of a large retrospective patient record review study on AEs was used. A stratified sample of 20 Dutch
hospitals was included. Excess length of stay and costs attributable to AEs and preventable AEs were calculated and
extrapolated to a national estimate. The association between patient characteristics and excess length of stay (and
costs thereof) attributable to AEs and preventable AEs was investigated through multilevel linear regression analyses.
Results: A total of 2975 patient records were included in the analysis, of which 325 experienced one or more AEs.
Hospital patients experiencing an AE stayed 5.11 (95 % CI 3.91–6.30) more days in hospital and cost €2600 (95 % CI
€1968–€3232) more compared to those without an AE. There was no significant difference in days and costs between
preventable and non-preventable AEs. Extrapolated to a national level, AEs cost more than €300 million, which was
1.3 % of the national hospital care budget. Patients with hospital-acquired infections had a statistically significant longer
length of stay compared to the reference group (patients with AEs on the cardiovascular system).
Conclusions: This study showed that AEs lead to substantial excess length of stay and increased costs. Special attention
should be paid to patients with AEs due to an hospital-acquired infection.
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Background
An AE is defined as an unintended injury that results in
temporary or permanent disability, death or prolonged
hospital stay, and is caused by healthcare management
rather than by the patient’s underlying disease process
[1]. Between 2.9 and 16.6 % of hospital patients experi-
enced an AE during their hospital admission [1–8].
Several studies showed that AEs are associated with
longer hospital length of stay (LOS). Excess LOS attrib-
utable to AEs ranges from 6 to 9 days [9–14], leading to
higher healthcare costs [15–25]. Earlier studies investigating
excess LOS and associated costs of AEs were mostly limited
to AEs caused by medication errors [15, 19, 23–25], or
investigated only costs associated with specific diseases or
treatment [17, 21, 22]. In the Netherlands, total direct
medical costs of AEs in hospitals were estimated using
patient records of 2004 [18]. The total annual direct
medical costs were estimated at €355 million for all AEs.
Since 2004, much has changed in the Dutch healthcare
system and utilisation of hospital care. Diagnosis Related
Groups (DRG’s) were introduced in hospital care in 2005 to
improve transparency and quality, by defining products
which can be negotiated between purchasers and providers
of care. The total hospital care costs rose from €15.5 billion
in 2004 to €23.9 billion in 2012, forcing hospitals to reduce
healthcare costs. Since the major part of the direct medical
costs in hospitals due to an AE consists of excess LOS [18],
insight into the excess LOS and costs associated with AEs
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is essential for determining economic consequences of
AEs and preventable AEs. This information may support
hospitals in justifying their investments in patient safety
interventions that will both improve patients’ health and
reduce avoidable health system costs.
Besides the economic consequences of AEs, information
should also be available about the patient’s characteristics
contributing to a longer LOS and higher costs if an AE
occurs. An earlier study showed that poorer health status
during admission was associated with increased AEs, and
also with increased costs and LOS [26]. The study of
Hoonhout et al. showed which determinants influenced
the costs attributable to AEs in 2004.
The aim of this study is to investigate the average and
extrapolated excess LOS and direct costs of AEs and
preventable AEs in Dutch hospitals. Furthermore, patient
characteristics associated with excess LOS and costs due
to AEs and preventable AEs will be evaluated.
Methods
Design and setting
For the present study, data of a large retrospective patient
record review study was used. This study was performed in
a random sample of 20 Dutch hospitals, stratified by
hospital type and location (urban or rural). Eligible hospitals
had at least 200 beds, an emergency department and an
intensive care unit. A total of four university-, eight tertiary
teaching- and eight general hospitals were included in the
sample. Tertiary teaching hospitals in The Netherlands pro-
vide specialised care and train doctors. The complexity of
care given is between that given in a university hospital and
in a general hospital. In each participating hospital, 200
patient admissions between April 1st 2011 and March 31st
2012 were randomly selected A large subsample (50 % of
the sample) of hospital patients who died in hospital during
admission, was included. This made it possible to estimate
the number of preventable deaths in the primary study as
this is a relatively small patient group. These patients were
sampled from all inpatient deaths The random sampling
was performed by giving random numbers to eligible
patients (with Excel) and to include number 1–100 of the
deceased patients and number 1–100 of the alive patients.
Patients admitted to the psychiatry department, obstetrics
and children <1 year old were excluded. More details about
the design and methods of the study have been described
elsewhere [27].
Patient record review
The nursing, medical, and – if available – outpatient
records of the sample patient admissions were reviewed
by 34 trained external nurses and 17 trained external
medical specialists (eight internists, seven surgeons and
two neurologists) in a two-stage review process. The
method of determining AEs was comparable to those of
other international studies [2, 3]. In the first stage a
nurse screened the records by using 16 triggers indicating
potential AEs. In the second phase, admissions positive for
at least one trigger were further reviewed by a physician.
Based on a standardised procedure, and preceded by a
number of underlying questions to secure a systematic
assessment, the presence and preventability of an AE was
determined. An AE was defined by three criteria:1) an
unintended (physical and/or mental) injury which results
in; 2) prolonged hospital stay, temporary or permanent
disability or death; and 3) is caused by healthcare manage-
ment rather than the patient’s condition.
An AE was found to be preventable when the care given
fell below the current level of expected performance for
practitioners or systems. The cause and preventability of
AEs were scored on a six-point Likert scale. A score of 4–6
indicated that the reviewer regarded the event as having a
greater than 50 % chance of being caused by healthcare, or
was preventable, and was considered as AE.
The AEs that occurred during the patient’s index hospital
admission and were detected during either the index
admission or subsequent admissions over the following 12-
month period were counted. AEs related to patient admis-
sions in the same hospital within the 12 months preceding
the index admission, but which were not detected until the
index admission were also counted. Consequently, patient
records of the index hospital admission were reviewed, as
were the patient records of patient admissions before and
after the index admission.
Additional data on the total Dutch hospital population
in 2011/2012 and administrative hospital information for
the reviewed patient admissions was collected from the
national hospital administration database (LMR) main-
tained by Dutch Hospital Data.
Excess length of stay
Within the LMR, for each hospital admission, the
expected LOS was computed. This calculation was based
on characteristics of the patients and the national mean
LOS that is associated with these characteristics [28].
The following characteristics of the patients were taken
into account:
 Age, divided into four classes: 1–14, 15–44, 45–64,
65+ years
 The primary diagnosis that resulted in the admission,
including about 1,000 diagnoses classified by the ICD9
in three digits
 Procedures, classified by the Dutch Classification
System of Procedures. The procedures considered
depend on the diagnosis of the patient.
Normally these calculations were only used for patients
discharged alive, but for the purpose of this study the
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expected LOS was also calculated for the patients which
died in hospital. The excess LOS during the index
admission was calculated by subtracting the expected LOS
from the actual observed LOS, using the LMR data. If
expected LOS in was missing within the LMR, the excess
LOS was imputed by estimations of extra hospital days
due to an AE indicated by the reviewer during the second
stage of the study. The estimates of excess LOS varied
from no extra bed days to all bed days of the index admis-
sion. For re-admissions attributable to AEs during the
index admission, we imputed the national average hospital
stay in 2012 (5.3 days).
Costs of excess LOS
To estimate direct costs of excess LOS, the calculated
excess LOS during index admission and re-admission was
multiplied by unit costs. The costs of one extra hospital
admission day was valued by the Dutch guideline prices of
2009 [29]. Only guideline prices for university and general
hospitals were available. For tertiary medical teaching
hospitals, guideline prices for general hospitals were used.
The unit costs include costs of a standard hospital day,
medical and nursing staff, medication, material, equipment,
housing and overhead. After correction with price indices
for 2012, the unit costs per day were €461.83 for general-
and tertiary medical teaching hospitals and €610.46 for
university hospitals. The unit costs per day were €2317.63
for intensive care units (ICUs).
Potential determinants
Several patient characteristics were investigated as
potential determinant for excess LOS and costs due to
AEs and preventable AEs. Age (in years), sex, urgent
admission (yes/no), and specialty (surgery versus non-
surgery) were collected within the patient record review.
ICD9 diagnostic information was gathered from the LMR
data and used to define diagnostic groups. The following
diagnostic groups were defined: neoplasm, endocrine, nu-
tritional and metabolic diseases, cardiovascular diseases,
respiratory system, digestive system, genitourinary system,
symptoms, signs and ill-defined conditions, and injury and
poisoning. All other diagnostic codes were defined as ‘all
other codes’.
Besides patient characteristics, type of AE was also
investigated as potential determinant for excess LOS and
costs due to AEs and preventable AEs.
Statistical analysis
The mean excess LOS and costs attributable to AEs and
preventable AEs with 95 % confidence intervals (CIs) were
estimated using multilevel linear regression analyses. A
two-level multilevel structure was used, whereby the
observations were clustered within hospitals. The national
estimate of excess LOS and costs attributable to AEs in
2011/2012 was calculated by multiplying total amount of
Dutch hospital admissions in the period April 1st 2011
and March 31st 2012 (n = 1.678.283) with AE rate (7.1 %)
[30] and by subsequently multiplying this with the extra
costs of an AE. The calculation was repeated for costs of
preventable AEs (1.6 % preventable AE rate).
Multilevel linear regression analyses were performed
to investigate the association between patient character-
istics and excess LOS attributable (and the costs thereof )
to AEs and preventable AEs. The dependent variable in
the model was either the excess LOS or the costs of
excess LOS. The independent variable was either AE or
preventable AE. The determinants were added as covari-
ates to the models. The variables included in the model
were centred to reference values for all Dutch hospital
admissions in 2011/2012. The variables ‘type of AE’ and
‘diagnostic groups’ were centred to the mean of these
variables in the total sample.
The amount of variation in excess LOS and costs of
AEs and preventable AEs caused by hospital level was
indicated by the Intraclass Correlation Coefficient (ICC)
[31]. The ICC is the ratio of between-group variance
and total variance, whereby a higher ICC represents a
larger variance between hospitals in AE rates and a
smaller variance within hospitals.
An additional analysis was performed to investigate
the costs of excess LOS including ICU days, as the costs
of ICU days are much higher compared to the costs of a
normal hospital day. ICU costs were not included in the
main analysis, because we had no information about the
exact number of ICU days caused by the AE. For
patients admitted to the ICU during their index admis-
sion, the number of days in ICU or intermediate care,
reported in the first stage of the review process, was
multiplied by unit costs of an ICU day. The remaining
days of the excess LOS were multiplied by unit costs per
day for the specified hospital type.
In all multilevel analyses, corrections were made for
overrepresentation of patients admitted to a university
hospital and for overrepresentation of patients who died
in hospital by adding these covariates to the model.
Descriptive analyses were performed using Stata 13.0.
Multilevel analyses were performed using MLwiN
version 2.24 (University of Bristol, 2011). For all analyses,
p-values ≤ .05 were considered statistically significant.
Results
During the first stage, a total of 4048 patient records
were reviewed by nurses. In the present study, patient
records with missing data for both expected LOS in the
LMR data and estimations of excess LOS by the reviewer
during the second stage of the study (n = 915) and with
missing data on any of the potential determinants for
excess LOS (n = 22) were excluded, resulting in a sample
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of 3111 patient records. LOS was imputed for 142
patient records (4.5 %) by the estimations indicated by
the reviewer. During the second stage, physicians identified
one or more AEs in 348 of these 3111 reviewed patient
admissions. For patients with multiple AEs, only records
with the first reported AEs (N = 325) were included in the
analysis, resulting in a total sample of 2975 patient records.
AEs were found to be preventable in 89 of the 325 patient
records. These numbers are unweighted.
Excess LOS and costs of (preventable) AEs
Table 1 shows mean excess LOS and costs attributable
to AEs following from the multilevel linear regression
analyses. The LOS of patients experiencing an AE was
5.11 days (95 % CI 3.91–6.30) longer compared to
patients without an AE. The mean extra costs of LOS
were €2600 (95 % CI 1968–3232) higher for patients
experiencing an AE compared to those without an AE.
There was no statistically significant difference (mean
difference 2.33 days; 95 % CI −1.19–5.85) in LOS
between preventable and non-preventable AEs. There
was no statistically significant difference (€1021; 95 %
CI −775–2817) in costs between preventable AE and
non-preventable AEs.
Extrapolating differences in costs due to an AE resulted
in an estimate of €309,812,233 extra costs attributable to
AEs in the Netherlands in 2011/2012. This was 1.3 % of
the national hospital care budget (€23.9 million) in 2012.
Per 100,000 patient admissions, the estimated extra costs
attributable to AEs were €18,460,071.
During the index admission, patients experiencing an AE
were more often admitted to intensive care or intermediate
care (45.5 %) compared to those without an AE (21.0 %).
The additional multilevel analysis showed a larger differ-
ence in costs (€6038; 95 % CI 4543–7533) between those
experiencing AEs compared to those without AEs when
the ICU costs were included. There was no statistically
significant difference (€2464; 95 % CI −2301–7230 ) in
costs between preventable AEs and non-preventable AEs.
Determinants of excess LOS and costs
Table 2 shows the results of the multilevel linear regres-
sion analysis of excess LOS and costs due to AEs. Excess
LOS differed statistically significantly between different
types of AE. Patients with a hospital-acquired infection
had a statistically significant longer excess LOS of 4.7 days
and €2337 higher costs compared to those with AEs on
the cardiovascular system. The costs of the excess LOS
due to AEs were €537 lower for urgent admissions
compared to those for planned admissions. No other
statistically significant determinants were found.
The multilevel analysis of excess LOS and costs due to
preventable AEs showed no statistically significant deter-
minants for excess LOS due to preventable AEs compared
to non-preventable AEs (table not shown).
Variation in excess LOS and costs
The variation in excess LOS was not caused by hospital
level as the ICC was 0.05 for AEs and 0.00 for prevent-
able AEs. A comparable result was found for variation in
costs, the ICC was 0.01 for AEs and 0.00 for preventable
AEs. This means that at most only 5 % of the variance in
excess LOS and costs was caused by differences in the
investigated determinants between individual hospitals.
The remaining variance is caused by differences in other
characteristics such as patient characteristics, organisation
characteristics, medical staff characteristics, technology
characteristics, or environment.
Discussion
The results of our study showed that patients experien-
cing an AE during hospitalisation stay five days longer in
hospital and cost €2600 more compared to those not
experiencing an AE. Extrapolation of our results showed
that total costs of excess LOS due to AEs was more than
€300 million in Dutch hospitals in 2011/2012. This was
1.3 % of the Dutch national hospital care budget in 2012.
AEs concerning hospital-acquired infections contributed to
longest excess LOS and highest costs. Urgently admitted
Table 1 Mean excess LOS and costs of AEs and preventable AEs in the Netherlands in 2011/2012a
N Mean excess LOS in days
(95 % CI)
Mean costs of excess
LOS in € (95 % CI)
Sensitivity analysis mean costs of excess
LOS in € (95 % CI)c
AE (N = 2975)
No 2650 2.43 (1.51–3.35) 1085 (695–1475) 1084 (354–1814)
Yes 325 7.53 (6.12–8.94)*** 3685 (2992–4378)*** 7122 (5577–8667)***
Preventable AE (N = 325)b
No 236 7.94 (5.28–10.60) 3906 (2580–5233) 4982 (1479–8484)
Yes 89 10.26 (6.52–14.00) 4927 (3034–6821) 7446 (2449–12443)
AE adverse event, LOS length of stay; ***P < 0.001
aIn all multilevel linear regression analyses mean excess LOS were corrected for overrepresentation of patients admitted to a university hospital and of
deceased patients
bNumber of patients experiencing an AE
cCosts of ICU days were included in the sensitivity analysis
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patients had lower costs of excess LOS due to AEs
compared to planned admissions. No statistically significant
difference in days and costs was found between preventable
and non-preventable AEs.
The mean excess LOS due to AEs was slightly lower
compared to results of previous studies in hospital patients.
Naessens et al. found a difference in excess LOS of 8.6 days
between hospital patients with and without an AE [26].
Ehsani et al. found a difference of 7.0 days between patients
with acute admission for cardiac disease experiencing AEs
and those without AEs [16]. The costs of excess LOS inves-
tigated in these two studies could not be compared to our
results, as they estimated total costs of patients from
hospital costing systems. Other recent studies considering
costs of LOS investigated only excess LOS due to adverse
drug events, and could therefore not be compared to our
results [15, 19, 24]. Compared to the results of 2004 [18],
the excess LOS was almost half of the days (5.1 compared
to 9.1 days). A reduction could have been expected, as there
was a nationwide downward trend in mean hospital LOS in
the last decade, from 7.3 days in 2004 to 5.3 days in 2012.
Possibly, increased awareness and earlier recognition of
consequences of AEs among healthcare providers contrib-
uted to more rapid action being taken.
Following the results of our study, patients with hospital-
acquired infections had a statistically longer LOS and
higher costs. This is in line with an observational study in
hospital patients, showing that a hospital-acquired infection
with Clostridium difficile increased the medium LOS by
6 days [32]. Implementation of possibilities for preventing
these infections should be investigated, for example
improving hand hygiene [33]. Urgently admitted patients
had lower costs attributable to AEs compared to planned
admissions. This might be the result of differences in the
Table 2 Multilevel regression analysis of the excess LOS and costs of AEs (N = 2975)
AE
N (%) Excess LOS Costs
Days SE € SE
AE (ref = no AE) 325 5.03*** 0.62 2536*** 192
Age −0.003 0.01 −3 6
Sex (ref = men) 1555 (52) 0.26 0.38 163 200
Urgent admission (reference = no) 2073 (70) −0.70 0.49 −537* 262
Surgery specialty (ref = non-surgery) 976 (33) −0.67 0.48 −385 253
Type of AE (ref = cardiovascular system)
Respiratory system 34 0.18 2.55 225 1355
Renal system 29 −0.14 2.64 −78 1401
Haematological system 20 2.27 2.89 1494 1536
Gastrointestinal event 30 −1.15 2.58 −706 1370
Neurological system 18 −3.32 2.94 −1653 1563
Hospital-acquired infection 79 4.70* 2.08 2337* 1104
Surgical or obstetric event 76 2.04 2.09 956 1112
Other type of AE 23 4.71 2.74 2415 1457
Diagnostic groups (ref = infection diseases)
Neoplasm 515 (17) 0.71 1.12 317 594
Endocrine, nutritional and metabolic diseases 57 (2) −0.18 1.70 −205 902
Cardiovascular diseases 759 (26) −1.06 1.09 −595 577
Respiratory system 309 (10) 0.10 1.17 56 622
Digestive system 276 (9) 1.29 1.20 781 637
Genitourinary system 147 (5) −0.45 1.34 −311 710
Symptoms, signs and ill-defined conditions 152 (5) 0.29 1.31 156 698
Injury and poisoning 266 (9) 0.14 1.22 141 648
All other codes 494 (17) −0.09 1.17 −112 623
ICCa hospital level (%) 5.0 % 0.01 %
AE adverse event, LOS length of stay, SE Standard Error, β difference;*P < 0.05; ***P < 0.001
aIntraclass correlation (ICC) is the ratio of the between-group variance and the total variance
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percentage of urgent admissions between hospital types: in
the more expensive academic hospitals fewer patients were
urgently admitted (59 %) compared to tertiary medical
teaching hospitals (71 %) and general hospitals (75 %).
An important strength of this study is that complete
patient admissions have been reviewed independently
by qualified nurses and physicians in a structured
manner to ascertain AEs. Another strength is the large
sample of hospitals and stratification by hospital type
and location, which enabled extrapolation of the results
to a national level.
Some limitations of our study have to be mentioned.
Despite the correction for the overrepresentation of
deceased patients, the calculated excess LOS might be
slightly overestimated. Deceased patients are probably
more severe patients compared to the discharged patients.
An additional analysis showed that the deceased patients
had a statistically significant (P < 0.001) longer excess LOS
of 1.67 days (95 % CI 0.88–2.45) compared to the
discharged patients. The calculated costs of AEs in our
study were presumably an underestimation of the total
costs within hospitals caused by AEs, because only costs of
excess LOS were included. Costs of extra medical proce-
dures attributable to AEs could not be taken into account
as the registration of these procedures was poor. This is a
result of the system (Diagnosis-related group, DRG), which
reimburses hospitals based on fixed prices for a combin-
ation of diagnosis and treatment, whereby procedures are
not declared individually. Hereby, the results of our study
could not be compared directly to other countries with
different health care and cost systems. The method used
for calculating excess LOS (observed LOS minus expected
LOS) may also have contributed to an underestimation of
the excess LOS [28]. However, this was the most accurate
available method to approach excess LOS due to an AE.
From a societal perspective, outpatient healthcare, product-
ivity loss and loss of income could also be important, as are
the potential costs for medical claims after an AE occurred.
However, these outcomes could not be taken into account
in our study. Despite these limitations in calculating excess
LOS, our study showed that AEs leads to substantial excess
LOS and costs.
Conclusions
This study showed that AEs leads to substantial excess LOS
and increased costs. No statistically significant difference
was found in excess LOS and costs between preventable
and non-preventable AEs. Extrapolating the results showed
that the total costs of excess LOS due to AEs in Dutch
hospitals was more than €300 million in 2011/2012. These
costs were approximately 1.3 % of the national hospital care
costs. Since patients with AEs due to an hospital-acquired
infection had a large increase of excess LOS, special
attention should be paid to these.
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